Core Laboratories NV

Find Ratings Reports
CLB : NYSE : Basic Materials
$123.32 | %
Today's Range: 122.39 - 124.34
Avg. Daily Volume: 443400.0
01/20/17 - 4:02 PM ET

Financial Analysis

CORE LABORATORIES NV's gross profit margin for the third quarter of its fiscal year 2016 has significantly decreased when compared to the same period a year ago. Sales and net income fell significantly; although net income growth outperformed the average competitor in its industry, revenue growth did not. CORE LABORATORIES NV has average liquidity. Currently, the Quick Ratio is 1.41 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

At the same time, stockholders' equity ("net worth") has greatly increased by 1,387.07% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q3 FY16 Q3 FY15
Net Sales ($mil)143.48197.27
EBITDA ($mil)27.9256.06
EBIT ($mil)21.249.15
Net Income ($mil)16.7333.4

Balance Sheet Q3 FY16 Q3 FY15
Cash & Equiv. ($mil)17.2218.46
Total Assets ($mil)562.14635.11
Total Debt ($mil)206.38428.0
Equity ($mil)157.59-12.24

Profitability Q3 FY16 Q3 FY15
Gross Profit Margin25.3234.58
EBITDA Margin19.4628.41
Operating Margin14.7824.92
Sales Turnover1.121.41
Return on Assets11.3526.07
Return on Equity40.510.0
Debt Q3 FY16 Q3 FY15
Current Ratio1.981.95
Interest Expense2.573.47
Interest Coverage8.2514.16

Share Data Q3 FY16 Q3 FY15
Shares outstanding (mil)44.142.41
Div / share0.550.55
Book value / share3.57-0.29
Institutional Own % n/a n/a
Avg Daily Volume451223.0502436.0


HOLD. CORE LABORATORIES NV's P/E ratio indicates a significant premium compared to an average of 69.72 for the Energy Equipment & Services industry and a significant premium compared to the S&P 500 average of 25.41. For additional comparison, its price-to-book ratio of 33.93 indicates a significant premium versus the S&P 500 average of 2.83 and a significant premium versus the industry average of 3.85. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, CORE LABORATORIES NV proves to trade at a premium to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
CLB 82.48 Peers 69.72   CLB 33.39 Peers 19.58

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

CLB is trading at a premium to its peers.


Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

CLB is trading at a significant premium to its peers.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
CLB 56.39 Peers 103.04   CLB NM Peers 0.27

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

CLB is trading at a discount to its peers.


Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

CLB's negative PEG ratio makes this valuation measure meaningless.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
CLB 33.93 Peers 3.85   CLB -61.52 Peers -384.15

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

CLB is trading at a significant premium to its peers.


Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

CLB is expected to have an earnings growth rate that significantly exceeds its peers.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
CLB 8.51 Peers 3.55   CLB -29.72 Peers -35.92

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

CLB is trading at a significant premium to its industry.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

CLB significantly trails its peers on the basis of sales growth



Latest Stock Upgrades/Downgrades